P648 Dietary therapy using a short course of Exclusive Enteral Nutrition followed by the Crohn’s Disease Exclusion Diet in children with mild to severe Crohn’s Disease; maintenance update on the DIETOMICS trial

R Sigall-Boneh,V Manuel Navas-López,S Hussey,G Pujol Muncunill,S Lawrence,H Jonsson Rolandsdotter,A Otley,J Martín-de-Carpi,L Abramas,M Herrador López,N Egea Castillo,M Chen,M Hurley,K Wingate,O Olen,M Yaakov,N Wierdsma,J Van Limbergen,E Wine

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0778

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background Exclusive enteral nutrition (EEN) is the first-line treatment for active Crohn’s disease (CD) in children. CD Exclusion Diet (CDED) combined with Partial Enteral Nutrition (PEN) has demonstrated better tolerance with a comparable effect in inducing remission among children with mild to moderate CD. This study evaluated the effectiveness of 2 weeks of EEN followed by CDED+PEN for maintaining remission for up to 24 weeks in children with mild-severe disease. Methods We conducted an international, multicenter, randomized controlled trial comparing 2 weeks of EEN using Modulen®, followed by 3 phases of the CDED+PEN (hereafter CDED), to 8 weeks of EEN followed by PEN with a free diet (hereafter EEN), all extended up to week 24 with a follow up till week 52. Children aged 8-18 with luminal CD duration less than 3 years, mild-severe disease [pediatric CD activity index (PCDAI),15-47.5], and active inflammation [elevated C-reactive protein (CRP),or fecal calprotectin (FC)] were included. Remission was defined as PCDAI≤10. Stable immunomodulator (IM) treatment was allowed, and naïve patients could initiate IM from week 4. Results We randomized 56 patients into two groups: Group CDED (n=30) and Group EEN (n=26); mean age 12.7±2.4, 37% female. Intention-to-treat analysis revealed remission in 18/30(60%) patients with CDED compared to 11/26(42%) with EEN at week 24,p=0.18 and 27% in CDED and 23% in EEN at week 52,p=0.75. Per protocol analysis showed 18/20(90%) remission in CDED compared to 11/14(78%) in EEN at week 8, p=0.35. Among patients who achieved remission at week 8, 18/23(78%) with CDED and 9/14(64%) with EEN maintained remission up to week 24, p=0.15. In CDED,15/20(75%) and 100% of EEN used IM, p=0.04. All CDED patients without IM remained in remission. Reduction of >50% in FC from baseline was obtained in 55% in the CDED and 28% in EEN, p=0.12. PCDAI improved from 31.2[20-35.6] to 5[0-12.5] in CDED and from 22.5[20-29.3] to 5[0-15.6] at week 24 in EEN, p<0.001 to all. CRP and FC significantly improved in both groups. Z score BMI improved from -1.3 [-2.1-(-0.1)] to -0.2 [-0.9-0.4], p=0.003 in CDED and from 0.08[-1.1-0.4] to 0.2[-1.7-0.7] at week 24 in EEN,p=0.098. Remission at week 2 (p=0.006) and overall high compliance (p=0.009) were identified as predictors of response at week 24. Conclusion While 2 weeks of EEN followed by CDED+PEN was not superior to EEN at 14 weeks (as previously reported), extending CDED+PEN for 24 weeks successfully maintained remission for up to 52 weeks in children with mild-to-severe CD. Moreover, a subset of patients maintained sustained clinical remission following CDED monotherapy. The long-term implementation of dietary therapy using CDED+PEN resulted in a significant improvement in nutritional status.

gastroenterology & hepatology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in pediatric patients with Crohn's Disease (CD), to evaluate whether a short - term Exclusive Enteral Nutrition (EEN) combined with Crohn’s Disease Exclusion Diet (CDED) and Partial Enteral Nutrition (PEN) dietary therapy can effectively maintain remission for up to 24 weeks, and to observe its long - term effects.

Specifically, the main objectives of the study include:

1. **Evaluating the effect of CDED + PEN after short - term EEN**: The study compared two treatment regimens:
- 2 weeks of EEN (using Modulen®), followed by 3 phases of CDED + PEN until week 24.
- 8 weeks of EEN, followed by a liberal diet and PEN until week 24.

2. **Effect on maintaining remission**: The study aimed to evaluate the ability of these two regimens to maintain remission, especially for children with mild - to - severe CD.

3. **Long - term effects and nutritional status**: The study also focused on the long - term effects of these dietary therapies on patients, including the improvement of nutritional status.

Through this study, the authors hope to provide new insights into the treatment of Crohn's disease in children and verify the effectiveness and feasibility of this combined dietary therapy.